Security key
03753U106
Apellis Pharmaceuticals, Inc. - Common Stock (APLS)
CUSIP: 03753U106
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 113,568,311
- Total 13F value
- $6,800,298,011
- Share change
- -218,768
- Put/Call ratio
- 36%
- SEC-reported price per share
- $59.86
- Number of holders
- 278
- Value change
- +$75,955,536
- Number of buys
- 127
- Number of sells
- 137
- Shares outstanding
- 127,672,507
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
278
Top holders
10
Broader feeds
Ownership snapshot
Top reported holders of APLS - Apellis Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
278
Shares
113,568,311
Rows available
278
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
250
Q4 2023 holders
278
Holder diff
28
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|